Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

pertuzumab 2 durvalumab 2 Paclitaxel 2 Nivolumab 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pembrolizumab 1 pamiparib 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Radiosurgery 1 Midazolam 1 LY3022855 1 LY2510924 1 Itraconazole 1 Irinotecan 1 Ipilimumab 1 Dextromethorphan 1 Carboplatin 1 CH5183284 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡